Skip to main content
GABY Inc. logo

GABY Inc. — Investor Relations & Filings

Ticker · GABY ISIN · CA36257J1021 CSE Manufacturing
Open in API
Filings indexed 221 across all filing types
Latest filing 2023-08-18 Board/Management Inform…
Country CA Canada
Listing CSE GABY

About GABY Inc.

http://www.gabyinc.com

GABY Inc. is a consumer packaged goods (CPG) company specializing in the production, marketing, sale, and retail of cannabis and hemp-derived wellness products in the United States. The company operates an integrated brands platform encompassing THC, CBD, and uninfused products. GABY maintains a retail focus, notably through its ownership of the Mankind dispensary in San Diego, California, and manages acquired CBD brands including HempFusion, Sagely Naturals, and apothecanna.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 95% confidence The document announces that GABY Inc. is winding down operations and that the Board of Directors and officers have resigned effective immediately. This is an official notice about significant changes in the company's management and operational status. There is no financial data, no report attached or referenced, and no mention of voting results or capital changes. The primary content is about changes in the company's board and management structure due to winding down operations. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and does not indicate a report publication or regulatory filing. Confidence is high due to clear announcement of board and officer resignations.
2023-08-18 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that GABY Inc. has exercised a reversion remedy related to a debt default and forfeited shares in a subsidiary in exchange for release of a $22.5 million debt. It details the terms of the foreclosure and release agreement, the resignation of a board member, and future business considerations. There are no financial statements, comprehensive financial data, or detailed management analysis present. The document is an announcement of a capital/financing event involving debt restructuring and share forfeiture. It is not an annual report, audit report, earnings release, or any other detailed financial report. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content support a high confidence in this classification.
2023-07-13 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing that GABY Inc. will not proceed with a previously proposed transaction with HempFusion. It references a prior announcement and provides background on the company and its stock listings. There is no financial data, no detailed report, no regulatory filing form, or voting results. The content is an update on a transaction status, which fits best under M&A Activity announcements. The document length is short and it is not a report publication announcement or certification. Therefore, the classification is M&A Activity (TAR).
2023-06-09 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-05-30 English
Interim MD&A - English.pdf
Regulatory Filings
2023-05-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-05-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.